Literature DB >> 25830040

Impact of the immune system and immunotherapy in colorectal cancer.

Janet L Markman1, Stephen L Shiao1.   

Abstract

The development of cancer is a multi-step process involving the gradual loss of regulation over the growth and functional capabilities of normal cells. Much research has been focused on the numerous cell intrinsic factors that govern this process; however, recent attention has turned to understanding the cell extrinsic factors in the tumor microenvironment that appear equally critical to the progression and treatment of cancer. One critical component of the tumor microenvironment is the immune system and it has become increasingly evident that the immune system plays an integral role in preventing and promoting the development of cancer. Understanding the immune cell types and pathways involved in this process has enabled the development of novel biomarkers for prognosis and accelerated the development of immune-based therapeutics, both of which have the potential to forever change the treatment paradigms for colorectal cancer (CRC). In this review, we discuss the impact of the immune system on the initiation, progression and treatment of cancer, specifically focusing on CRC.

Entities:  

Keywords:  Immune system; colorectal cancer (CRC); immunotherapy; inflammation

Year:  2015        PMID: 25830040      PMCID: PMC4311093          DOI: 10.3978/j.issn.2078-6891.2014.077

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  120 in total

1.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

Review 2.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 3.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

4.  Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.

Authors:  Thinle Chodon; Begoña Comin-Anduix; Bartosz Chmielowski; Richard C Koya; Zhongqi Wu; Martin Auerbach; Charles Ng; Earl Avramis; Elizabeth Seja; Arturo Villanueva; Tara A McCannel; Akira Ishiyama; Johannes Czernin; Caius G Radu; Xiaoyan Wang; David W Gjertson; Alistair J Cochran; Kenneth Cornetta; Deborah J L Wong; Paula Kaplan-Lefko; Omid Hamid; Wolfram Samlowski; Peter A Cohen; Gregory A Daniels; Bijay Mukherji; Lili Yang; Jerome A Zack; Donald B Kohn; James R Heath; John A Glaspy; Owen N Witte; David Baltimore; James S Economou; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

5.  Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests.

Authors:  W J Lesterhuis; I J M de Vries; D H Schuurhuis; A C I Boullart; J F M Jacobs; A J de Boer; N M Scharenborg; H M H Brouwer; M W M M van de Rakt; C G Figdor; T J Ruers; G J Adema; C J A Punt
Journal:  Ann Oncol       Date:  2006-04-06       Impact factor: 32.976

6.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

Review 7.  Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Authors:  F Pagès; J Galon; M-C Dieu-Nosjean; E Tartour; C Sautès-Fridman; W-H Fridman
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

8.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

9.  Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Authors:  Bin Zhang; Zhijun Wang; Liangliang Wu; Meng Zhang; Wei Li; Jianhua Ding; Jun Zhu; Huafeng Wei; Ke Zhao
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression.

Authors:  Sofia R Gameiro; Jack P Higgins; Matthew R Dreher; David L Woods; Goutham Reddy; Bradford J Wood; Chandan Guha; James W Hodge
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more
  66 in total

1.  PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.

Authors:  David C Qian; Xiangjun Xiao; Jinyoung Byun; Arief A Suriawinata; Stephanie C Her; Christopher I Amos; Richard J Barth
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

Review 2.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

3.  Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer.

Authors:  Francesca Mion; Stefania Vetrano; Silvia Tonon; Viviana Valeri; Andrea Piontini; Alessia Burocchi; Luciana Petti; Barbara Frossi; Alessandro Gulino; Claudio Tripodo; Mario P Colombo; Carlo E Pucillo
Journal:  Oncoimmunology       Date:  2017-06-19       Impact factor: 8.110

Review 4.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

5.  Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.

Authors:  Yao Zhang; Na Diao; Christina K Lee; Hong Wei Chu; Lan Bai; Liwu Li
Journal:  Mol Ther       Date:  2019-09-23       Impact factor: 11.454

Review 6.  Immunotherapy in colorectal cancer: for the select few or all?

Authors:  Sukeshi Patel Arora; Devalingam Mahalingam
Journal:  J Gastrointest Oncol       Date:  2018-02

Review 7.  The emerging role of immunotherapy in colorectal cancer.

Authors:  David Lynch; Adrian Murphy
Journal:  Ann Transl Med       Date:  2016-08

Review 8.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

9.  Systemic and local inflammation in colorectal cancer.

Authors:  Roberts Rumba; Sandra Cipkina; Fanija Cukure; Andrejs Vanags
Journal:  Acta Med Litu       Date:  2018

10.  Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis.

Authors:  Amy I Yu; Lili Zhao; Kathryn A Eaton; Sharon Ho; Jiachen Chen; Sara Poe; James Becker; Allison Gonzalez; Delaney McKinstry; Muneer Hasso; Jonny Mendoza-Castrejon; Joel Whitfield; Charles Koumpouras; Patrick D Schloss; Eric C Martens; Grace Y Chen
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.